Your browser doesn't support javascript.
loading
Polypharmacology of ambroxol in the treatment of COVID-19.
Wang, Ziyuan; Yang, Minghui; Chen, Xi; Xiao, Rongxin; Dong, Yu; Chu, Ming; Song, Guojie; Wang, Yuedan.
Afiliación
  • Wang Z; Department of Immunology, School of Basic Medical Sciences, Peking University, NHC Key Laboratory of Medical Immunology (Peking University), Beijing, China.
  • Yang M; Department of Immunology, School of Basic Medical Sciences, Peking University, NHC Key Laboratory of Medical Immunology (Peking University), Beijing, China.
  • Chen X; The Third Clinical Department of China Medical University, Shenyang, Liaoning, China.
  • Xiao R; Department of Adult Joint Reconstructive Surgery, Beijing Jishuitan Hospital, Fourth Clinical College of Peking University, Jishuitan Orthopaedic College of Tsinghua University, Beijing, China.
  • Dong Y; Department of Thoracic Surgery, Peking University People's Hospital, Beijing, China.
  • Chu M; Department of Immunology, School of Basic Medical Sciences, Peking University, NHC Key Laboratory of Medical Immunology (Peking University), Beijing, China.
  • Song G; Department of Immunology, School of Basic Medical Sciences, Peking University, NHC Key Laboratory of Medical Immunology (Peking University), Beijing, China.
  • Wang Y; Department of Artificial Intelligence, School of Intelligence Science and Technology, Peking University, Beijing, China.
Biosci Rep ; 43(2)2023 02 27.
Article en En | MEDLINE | ID: mdl-36651548

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Ambroxol / COVID-19 Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Biosci Rep Año: 2023 Tipo del documento: Article País de afiliación: China

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Ambroxol / COVID-19 Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Biosci Rep Año: 2023 Tipo del documento: Article País de afiliación: China